跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
圣利卓 - NMPA Drug Approval Details
Approvals
/
NMPA
/
spesolimab injection
Approved
生物制品
spesolimab injection
Boehringer Ingelheim International GmbH
🇨🇳 National Medical Products Administration
Approval Date
Dec 13, 2022
Approval ID
2abbee22d81fb012
Company
Boehringer Ingelheim International GmbH
Type
生物制品
Approval Details
Approval Id
2abbee22d81fb012
Approval Number
国药准字SJ20220020
Generic Name
佩索利单抗注射液
Generic Name En
spesolimab injection
Trade Name
圣利卓
Drug Type
生物制品
Dosage Form
注射剂
Strength
450 mg(7.5 mL)/瓶
Reg Date
2022-12-13
Expired Date
2027-12-12
Company Name
Boehringer Ingelheim International GmbH
Production Company Name
Boehringer Ingelheim Pharma GmbH & Co. KG
Company Detail Path
/organization/boehringer-ingelheim-international-gmbh
Production Company Detail Path
/organization/boehringer-ingelheim-pharma-gmbh-and-co-kg
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Dec 13, 2022
Approval ID
2abbee22d81fb012
Type
生物制品
Back to NMPA Approvals